{"id":22477,"title":"Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO) Randomized Trial: Baseline analysis protocol by C. King (P. Korthuis team)","title_html":"Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO) Randomized Trial: Baseline analysis protocol by C. King (P. Korthuis team)","image":{"source":"https:\/\/www.protocols.io\/img\/default_protocol.png","placeholder":"https:\/\/www.protocols.io\/img\/default_protocol.png"},"doi":"dx.doi.org\/10.17504\/protocols.io.z7mf9k6","doi_status":2,"uri":"buprenorphine-to-improve-hiv-care-engagement-and-o-z7mf9k6","type_id":1,"published_on":1555730560,"version_id":0,"created_on":1555701007,"categories":null,"creator":{"name":"Caroline King","affiliation":"Oregon Health Sciences University","username":"caroline-king","link":null,"image":{"source":"https:\/\/s3.amazonaws.com\/pr-journal\/bf226gdn.png","placeholder":"https:\/\/s3.amazonaws.com\/pr-journal\/bf226gdn.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"}],"research_interests":null},"journal":null,"journal_name":null,"journal_link":null,"public":1,"has_versions":0,"link":null,"total_collections":0,"number_of_steps":9,"authors":[{"name":"Caroline King","affiliation":"Oregon Health Sciences University","username":"caroline-king","link":null,"image":{"source":"https:\/\/s3.amazonaws.com\/pr-journal\/bf226gdn.png","placeholder":"https:\/\/s3.amazonaws.com\/pr-journal\/bf226gdn.png"},"badges":[],"research_interests":null}],"versions":[],"groups":[],"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"steps":[{"id":732386,"guid":"BECFE5D062D611E98342F76D0C97ADB0","previous_id":null,"previous_guid":null,"modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"88B878B5028C4BC789A4260A9796185E","order_id":1,"type_id":6,"title":"Section","source":{"title":"Overview"}},{"id":1054724,"guid":"8457FAD7C1454848BDD93DB2D7E7046D","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>This protocol is for data analysis as part of the<\/span><span style = \"font-weight:bold;\"> Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO) Randomized Trial<\/span><span>. The BRAVO trial enrolled patients with HIV and moderate-to-severe opiate use disorder to receive either methadone maintenance therapy (MMT) or buprenorphine\/naloxone (BUP\/NX) at six Vietnamese HIV clinical research sites between 2015 and 2019.<\/span><\/div><\/div>"}}],"cases":null,"data":null,"section":null,"section_color":null},{"id":732387,"guid":"E84A8E2062DF11E98342F76D0C97ADB0","previous_id":732386,"previous_guid":"BECFE5D062D611E98342F76D0C97ADB0","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"6AE3218B69654903B98EE79CF78F0ED7","order_id":1,"type_id":6,"title":"Section","source":{"title":"Study Outcome"}},{"id":1054724,"guid":"7A067F62C2334C7EB8C529E88174E2D9","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>The<\/span><span style = \"font-weight:bold;\"> study outcome <\/span><span>is HIV suppression at time of enrollment, quantified as less than 200 copies of HIV-1 RNA virus in lab testing. <\/span><\/div><\/div>"}}],"cases":null,"data":null,"section":null,"section_color":null},{"id":732388,"guid":"2FAAF48062E011E98342F76D0C97ADB0","previous_id":732387,"previous_guid":"E84A8E2062DF11E98342F76D0C97ADB0","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"BC7C01D9FF544EDFA40B7D11CC361D36","order_id":1,"type_id":6,"title":"Section","source":{"title":"Covariates"}},{"id":1054724,"guid":"8EB821AC18654EBCAE1D272B8C2A0A6C","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Binary and categorical covariates<\/span><span> included gender (male\/female), greater than 9<\/span><span style = \"vertical-align:super;\">th<\/span><span> grade education (yes\/no), currently employed (yes\/no), currently married (yes\/no), currently on ART (yes\/no), Hep B positive (yes\/no), Hep C antibody positive (yes\/no), positive tuberculosis screen (yes\/no), history of 06 rehabilitation (yes\/no), and other drug use (methamphetamine or amphetamines\/methadone\/buprenorphine\/daily tobacco use\/heavy alcohol use\/none). Heavy alcohol use will be defined using the AUDIT score. <\/span><\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Continuous covariates <\/span><span>include mean age and years since HIV diagnosis at the time of diagnosis. <\/span><\/div><div class = \"text-block\">Age will be reclassified into 10-year categories during covariate testing to increase usefulness in study results. <\/div><\/div>"}}],"cases":null,"data":null,"section":null,"section_color":null},{"id":732389,"guid":"4221848062E011E98342F76D0C97ADB0","previous_id":732388,"previous_guid":"2FAAF48062E011E98342F76D0C97ADB0","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"1C86FBAA3231487A94FF993BA239F779","order_id":1,"type_id":6,"title":"Section","source":{"title":"Data Analysis"}},{"id":1054724,"guid":"8CB8D82886C14AD2B47D2D047550E4CF","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Primary Analysis<\/span><\/div><div class = \"text-block\">Two logistical regression models (univariate + age and sex, and univariate + all covariates) will be built to model the relationship of baseline participant characteristics with the binary variable for HIV suppression (HIV-1 RNA < 200 copies\/mL). <\/div><\/div>"}}],"cases":null,"data":null,"section":null,"section_color":null},{"id":732390,"guid":"47C54DE062E011E98342F76D0C97ADB0","previous_id":732391,"previous_guid":"4F3EE8B062E011E98342F76D0C97ADB0","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"060CD26027104AF8B02649AEDDBDE5A2","order_id":1,"type_id":6,"title":"Section","source":{"title":"Data Analysis"}},{"id":1054724,"guid":"430B404E3E9F4BFEA99B799A16D93E2F","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Missing Data<\/span><\/div><div class = \"text-block\">Missing HIV viral load at baseline will be imputed as \u201cnot suppressed\u201d. We anticipate minimal missingness in baseline data among covariates, and will analyze this data using complete case analysis.<\/div><\/div>"}}],"cases":null,"data":null,"section":null,"section_color":null},{"id":732391,"guid":"4F3EE8B062E011E98342F76D0C97ADB0","previous_id":732389,"previous_guid":"4221848062E011E98342F76D0C97ADB0","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"A84834B8F0194B22B4FCCF247BFF08D7","order_id":1,"type_id":6,"title":"Section","source":{"title":"Data Analysis"}},{"id":1054724,"guid":"252D2FE1FAF64B119D9285C76D4044D2","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Model Fitting<\/span><\/div><div class = \"text-block\">We will fit the logistic regression using an estimated covariate ratio of 10 events per degree of freedom.<\/div><div class = \"text-block\">All continuous covariates will be evaluated for linearity in the log-odds using Lowess scatter plot (comparing HIV suppression and each continuous covariate, individually). Covariates will be examined for multi-collinearity. If covariates are colinear (p>0.80), the research team has decided to include covariates with more variability among participants; where variability is similar, the research team will consult the clinical team for guidance. <\/div><\/div>"}}],"cases":null,"data":null,"section":null,"section_color":null},{"id":732392,"guid":"9011C1F062E011E98342F76D0C97ADB0","previous_id":732390,"previous_guid":"47C54DE062E011E98342F76D0C97ADB0","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"305AE85D939E432F80C82BDF5D8B069A","order_id":1,"type_id":6,"title":"Section","source":{"title":"Data Analysis"}},{"id":1054724,"guid":"9F9EB6C38DCE4967B58383952F5563D6","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Model testing<\/span><\/div><div class = \"text-block\">We will carry out Hosmer-Lemeshow tests for regression models to ensure the models are well-fit, using an alpha level of 0.05.  <\/div><\/div>"}}],"cases":null,"data":null,"section":null,"section_color":null},{"id":732393,"guid":"909808F062E011E98342F76D0C97ADB0","previous_id":732392,"previous_guid":"9011C1F062E011E98342F76D0C97ADB0","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"B8458981FA29482B97F314B8BB750BCC","order_id":1,"type_id":6,"title":"Section","source":{"title":"Data Analysis"}},{"id":1054724,"guid":"083C96C989DD4176A50466D2E8A33EB4","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Sensitivity analysis<\/span><\/div><div class = \"text-block\">One sensitivity analysis for the regression model will be conducted. Influential observations will be identified using Pregibon\u2019s Delta-Beta statistic; observations with a Delta-Beta statistic greater than 0.20 were removed. Significant sensitivity analysis results will be reported alongside primary analysis results. <\/div><\/div>"}}],"cases":null,"data":null,"section":null,"section_color":null},{"id":732394,"guid":"C4EBE0E062E011E98342F76D0C97ADB0","previous_id":732393,"previous_guid":"909808F062E011E98342F76D0C97ADB0","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"07C88A4E91E24E3A9BBB75EFF25231FD","order_id":1,"type_id":6,"title":"Section","source":{"title":"Technology"}},{"id":1054724,"guid":"08AB356004154244858A0B928F613ACA","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">All data will be analyzed using Stata IC Version 15. <\/div><\/div>"}}],"cases":null,"data":null,"section":null,"section_color":null}],"materials":[],"description":"","changed_on":1555730560}